Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
Harvard Business School
Citi
Teva
Queensland Health
Chubb
Julphar
Healthtrust
UBS

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,588,580

« Back to Dashboard

Summary for Patent: 4,588,580
Title: Transdermal administration of fentanyl and device therefor
Abstract:Transdermal delivery systems for delivery of fentanyl and its analgetically effective derivatives for extended periods of time are disclosed which deliver the base form of the drug at a rate of from 0.5 to 10 .mu.g/cm.sup.2 /hr for a substantial portion of their useful life. The systems can be from 5-100 cm.sup.2 in releasing surface and preferably employ an in-line amine resistant adhesive. Preferred rate controlled systems utilize an aqueous ethanolic gel to minimize drug content.
Inventor(s): Gale; Robert M. (Los Altos, CA), Goetz; Victor (Palo Alto, CA), Lee; Eun S. (Redwood City, CA), Taskovich; Lina T. (Palo Alto, CA), Yum; Su I. (Los Altos, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:06/633,762
Patent Claim Types:
see list of patent claims
Process; Delivery; Device;

Drugs Protected by US Patent 4,588,580

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,588,580

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 4452785 ➤ Sign Up
Australia 565177 ➤ Sign Up
Belgium 902884 ➤ Sign Up
Belgium 905568 ➤ Sign Up
Canada 1245983 ➤ Sign Up
Switzerland 665351 ➤ Sign Up
Cyprus 1560 ➤ Sign Up
Germany 3526339 ➤ Sign Up
Germany 3546830 ➤ Sign Up
Germany 3546869 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Merck
Cantor Fitzgerald
Teva
Chinese Patent Office
Colorcon
Argus Health
Covington
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot